Author/Authors :
Fujiki، نويسنده , , Akira and Tsuneda، نويسنده , , Takayuki and Sugao، نويسنده , , Masataka and Mizumaki، نويسنده , , Koichi and Inoue، نويسنده , , Hiroshi، نويسنده ,
Abstract :
The aim of this study was to investigate the efficacy and safety of bepridil (a multichannel blocker including several potassium channels) for conversion of long-lasting atrial fibrillation (AF). Bepridil restored sinus rhythm alone or in combination with aprindine in 69% of 32 patients with persistent AF lasting ≥3 months. The time to conversion after starting bepridil was 30 ± 12 days. An increase in fibrillation cycle length with bepridil was greater in responders (31 ± 10%), but an increase in QTc did not differ between responders and nonresponders. Bepridil is effective and safe for terminating long-lasting persistent AF.